| class name | count |
|---|---|
| rosids | 5 |
| asterids | 4 |
| eudicotyledons | 3 |
| class name | count |
|---|---|
| Rutaceae | 4 |
| Crassulaceae | 2 |
| Solanaceae | 2 |
| Asteraceae | 2 |
| Caryophyllaceae | 1 |
| Cucurbitaceae | 1 |
| Pyralidae | 1 |
| br08003 Category | # of metabolite |
|---|
| br08003 Category | KEGG ID | KNApSAcK ID |
|---|
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
|---|---|---|---|---|---|---|
|
C00000358
|
n-Hexanol
|
CHEMBL14085
|
C036260
|
3 / 6 / 3 |
|
|
|
C00035784
|
1-Pentanol
/ n-Pentanol |
CHEMBL14568
|
C024999
|
2 / 7 / 5 | 2 / 0 |
|
|
C00035814
|
Butanol
|
CHEMBL14245
|
D020001
|
2 / 0 / 1 | 40 / 1 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| Q16637 | Survival motor neuron protein | Unclassified protein | C00035784 | 4 / 1 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | C00000358 | 3 / 2 |
| P10828 | Thyroid hormone receptor beta | NR1A2 | C00000358 | 3 / 1 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | C00035814 | 0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | C00035814 | 0 / 1 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000358 | 0 / 0 |
| P10275 | Androgen receptor | NR3C4 | C00035784 | 3 / 4 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1135 | CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) |
C00035784
C00035814
|
| 1143 | CHRNB4 | cholinergic receptor, nicotinic, beta 4 (neuronal) |
C00035784
C00035814
|
| 9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00035814
|
| 183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00035814
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00035814
|
| 240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) |
C00035814
|
| 382 | ARF6 | ADP-ribosylation factor 6 |
C00035814
|
| 727 | C5, C5a, C5b, CPAMD4 | complement component 5 |
C00035814
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00035814
|
| 896 | CCND3 | cyclin D3 |
C00035814
|
| 1137 | CHRNA4, BFNC, EBN, EBN1, NACHR, NACHRA4, NACRA4 | cholinergic receptor, nicotinic, alpha 4 (neuronal) |
C00035814
|
| 1141 | CHRNB2, EFNL3, nAChRB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) |
C00035814
|
| 2268 | FGR, SRC2, c-fgr, c-src2, p55-Fgr, p55c-fgr, p58-Fgr, p58c-fgr | feline Gardner-Rasheed sarcoma viral oncogene homolog (EC:2.7.10.2) |
C00035814
|
| 2554 | GABRA1, ECA4, EJM, EJM5 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
C00035814
|
| 2561 | GABRB2 | gamma-aminobutyric acid (GABA) A receptor, beta 2 |
C00035814
|
| 2566 | GABRG2, CAE2, ECA2, GEFSP3 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
C00035814
|
| 2688 | GH1, GH, GH-N, GHN, IGHD1B, hGH-N | growth hormone 1 |
C00035814
|
| 2911 | GRM1, GPRC1A, MGLU1, MGLUR1, SCAR13 | glutamate receptor, metabotropic 1 |
C00035814
|
| 2915 | GRM5, GPRC1E, MGLUR5, mGlu5 | glutamate receptor, metabotropic 5 |
C00035814
|
| 3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00035814
|
| 19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00035814
|
| 3484 | IGFBP1, AFBP, IBP1, IGF-BP25, PP12, hIGFBP-1 | insulin-like growth factor binding protein 1 |
C00035814
|
| 3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00035814
|
| 3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00035814
|
| 3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00035814
|
| 5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00035814
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00035814
|
| 5028 | P2RY1, P2Y1 | purinergic receptor P2Y, G-protein coupled, 1 |
C00035814
|
| 5155 | PDGFB, IBGC5, PDGF-2, PDGF2, SIS, SSV, c-sis | platelet-derived growth factor beta polypeptide |
C00035814
|
| 5338 | PLD2 | phospholipase D2 (EC:3.1.4.4) |
C00035814
|
| 5579 | PRKCB, PKC-beta, PKCB, PRKCB1, PRKCB2 | protein kinase C, beta (EC:2.7.11.13) |
C00035814
|
| 5590 | PRKCZ, PKC-ZETA, PKC2 | protein kinase C, zeta (EC:2.7.11.13) |
C00035814
|
| 5617 | PRL | prolactin |
C00035814
|
| 5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00035814
|
| 5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00035814
|
| 6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00035814
|
| 6199 | RPS6KB2, KLS, P70-beta, P70-beta-1, P70-beta-2, S6K-beta2, S6K2, SRK, STK14B, p70(S6K)-beta, p70S6Kb | ribosomal protein S6 kinase, 70kDa, polypeptide 2 (EC:2.7.11.1) |
C00035814
|
| 8877 | SPHK1, SPHK | sphingosine kinase 1 (EC:2.7.1.91) |
C00035814
|
| 412 | STS, ARSC, ARSC1, ASC, ES, SSDD, XLI | steroid sulfatase (microsomal), isozyme S (EC:3.1.6.2) |
C00035814
|
| 7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00035814
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
| #274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
| #145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
| KEGG | name | UniProt |
|---|---|---|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|